A new report questions whether digital diabetes programs are worth the cost
26 Mar 2024
AHA
(This story is from our new Health Tech newsletter. If you’d like to sign up,
just click here
.)
Employers, insurers and investors have long been pouring money into programs aimed at helping Americans better manage their chronic conditions. But a recent study found that many of the programs available to manage type 2 diabetes don’t deliver results that justify the price tag.
The
report
by the Peterson Health Technology Institute released Thursday evaluated studies from eight digital tools used to care for people with type 2 diabetes. While the tools did reduce levels of hbA1c, an indicator for blood sugar levels, the reductions were too small to be clinically significant. The programs also drive up overall healthcare costs, the study said. Virta Health’s program, however, which uses a diet-based approach to manage diabetes, showed promising results.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-Drugs
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.